Positive leadership communication can be an effective tool to reduce turnover and burnout among employees in the healthcare ...

The cathepsin C (CatC) inhibitor BI 1291583 is associated with a decreased risk for an exacerbation in adults with bronchiectasis.

Neffy, an intranasal formulation of epinephrine, is now available for emergency treatment of type I allergic reactions.

FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and ...

In lung transplantation, a short-term heparin-free ECMO anticoagulation strategy is safe and feasible perioperatively.

The U.S. government is offering another round of free COVID-19 tests, which will be available by the end of September.

Following COVID-19 vaccination, most patients with MS do not face an increased risk for relapse requiring corticosteroid therapy.

Multiple myeloma patients with COVID-19 have high rates of hospitalization, ICU admission, and death, according to researchers.

SGLT-2 inhibitors were associated with the lowest risk for incidental dementia relative to DPP-4 inhibitors and GLP-1RAs in type 2 diabetes.

Long COVID is common among veterans in the Airborne Hazards and Open Burn Pit Registry; however, the risk is not augmented by deployment exposures.

The aTIV vaccine provides better protection against influenza-related medical encounters than the HD-TIV vaccine in high-risk older adults.

Gamified digital mental health interventions (DMHIs) may offer benefits for youth with attention-deficit/hyperactivity disorder (ADHD) or depressive disorder.